VitaSpring Biomedical (VSBC) Stock Statistics & Valuation Metrics

VitaSpring Biomedical has a market cap or net worth of $2.30M. The enterprise value is $2.53M.

VitaSpring Biomedical has 207,030,030 shares outstanding. The number of shares has decreased by -2.65% in one year.

VitaSpring Biomedical’s return on equity (ROE) is 1.74 and return on invested capital (ROIC) is 195.57%.

The current PE Ratio of VitaSpring Biomedical is ―. VitaSpring Biomedical’s PEG ratio is 1.72.

In the last 12 months, VitaSpring Biomedical had revenue of 0.00 and earned -4.16M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -239.51K and capital expenditures -662.00, giving a free cash flow of -240.17K billion.

VitaSpring Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

VitaSpring Biomedical upcoming earnings date is ―, ―.

VitaSpring Biomedical as a current ratio of 0.14, with Debt / Equity ratio of -10.97%

In the past 12 months, VitaSpring Biomedical has paid -5.38K in taxes.

VitaSpring Biomedical EV to EBITDA ratio is -780.57, with an EV/FCF ratio of -39.76K.

VitaSpring Biomedical has $24.05K in cash and marketable securities with $329.63K in debt, giving a net cash position of -$305.58K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for VitaSpring Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―